+102.2%
USO vs GSK
+14.9%
+87.2%
-32.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -8.1% | +5.0% | -13.1% | -5.5% |
| 7D | -12.7% | +4.9% | -17.6% | -10.3% |
| 30D | +1.0% | +9.9% | -8.9% | +6.2% |
| 3M | +25.6% | +0.2% | +25.4% | +26.2% |
| 6M | -1.5% | +2.3% | -3.8% | +0.8% |
| YTD | +110.3% | +7.1% | +103.2% | +106.4% |
| 1Y | +102.2% | +13.1% | +89.0% | +97.3% |
| All | +102.2% | +14.9% | +87.2% | +97.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling